nodes	percent_of_prediction	percent_of_DWPC	metapath
Lercanidipine—CYP3A7-CYP3A51P—Irinotecan—colon cancer	0.126	0.175	CbGbCtD
Lercanidipine—CYP3A7—Irinotecan—colon cancer	0.126	0.175	CbGbCtD
Lercanidipine—CYP3A7—Vincristine—colon cancer	0.11	0.153	CbGbCtD
Lercanidipine—CYP3A7-CYP3A51P—Vincristine—colon cancer	0.11	0.153	CbGbCtD
Lercanidipine—CYP3A5—Irinotecan—colon cancer	0.0946	0.132	CbGbCtD
Lercanidipine—CYP3A5—Vincristine—colon cancer	0.0827	0.115	CbGbCtD
Lercanidipine—CYP3A4—Irinotecan—colon cancer	0.0369	0.0513	CbGbCtD
Lercanidipine—CYP3A4—Vincristine—colon cancer	0.0322	0.0448	CbGbCtD
Lercanidipine—Nisoldipine—ABCB1—colon cancer	0.000956	0.243	CrCbGaD
Lercanidipine—Nitrendipine—ABCB1—colon cancer	0.000894	0.228	CrCbGaD
Lercanidipine—Angina pectoris—Capecitabine—colon cancer	0.000742	0.00268	CcSEcCtD
Lercanidipine—Sweating increased—Capecitabine—colon cancer	0.000742	0.00268	CcSEcCtD
Lercanidipine—Ill-defined disorder—Irinotecan—colon cancer	0.000735	0.00266	CcSEcCtD
Lercanidipine—Anaemia—Irinotecan—colon cancer	0.000733	0.00265	CcSEcCtD
Lercanidipine—Vertigo—Vincristine—colon cancer	0.000731	0.00264	CcSEcCtD
Lercanidipine—Hepatic failure—Methotrexate—colon cancer	0.00073	0.00263	CcSEcCtD
Lercanidipine—Pancytopenia—Capecitabine—colon cancer	0.000723	0.00261	CcSEcCtD
Lercanidipine—Vision blurred—Fluorouracil—colon cancer	0.000715	0.00258	CcSEcCtD
Lercanidipine—Malaise—Irinotecan—colon cancer	0.000715	0.00258	CcSEcCtD
Lercanidipine—Vertigo—Irinotecan—colon cancer	0.000712	0.00257	CcSEcCtD
Lercanidipine—Neutropenia—Capecitabine—colon cancer	0.000712	0.00257	CcSEcCtD
Lercanidipine—Felodipine—ABCB1—colon cancer	0.000712	0.181	CrCbGaD
Lercanidipine—Syncope—Irinotecan—colon cancer	0.000711	0.00257	CcSEcCtD
Lercanidipine—Anaemia—Fluorouracil—colon cancer	0.000702	0.00253	CcSEcCtD
Lercanidipine—Loss of consciousness—Irinotecan—colon cancer	0.000697	0.00252	CcSEcCtD
Lercanidipine—Dermatitis exfoliative—Methotrexate—colon cancer	0.000695	0.00251	CcSEcCtD
Lercanidipine—Photosensitivity reaction—Capecitabine—colon cancer	0.000695	0.00251	CcSEcCtD
Lercanidipine—Myalgia—Vincristine—colon cancer	0.000693	0.0025	CcSEcCtD
Lercanidipine—Cough—Irinotecan—colon cancer	0.000692	0.0025	CcSEcCtD
Lercanidipine—Nifedipine—ABCB1—colon cancer	0.000688	0.175	CrCbGaD
Lercanidipine—Nicardipine—ABCB1—colon cancer	0.000678	0.173	CrCbGaD
Lercanidipine—Stevens-Johnson syndrome—Capecitabine—colon cancer	0.000673	0.00243	CcSEcCtD
Lercanidipine—Acute coronary syndrome—Capecitabine—colon cancer	0.000669	0.00242	CcSEcCtD
Lercanidipine—Cerebrovascular accident—Methotrexate—colon cancer	0.000669	0.00242	CcSEcCtD
Lercanidipine—Renal failure—Capecitabine—colon cancer	0.000667	0.00241	CcSEcCtD
Lercanidipine—Discomfort—Irinotecan—colon cancer	0.000667	0.00241	CcSEcCtD
Lercanidipine—Myocardial infarction—Capecitabine—colon cancer	0.000665	0.0024	CcSEcCtD
Lercanidipine—Neuropathy peripheral—Capecitabine—colon cancer	0.000665	0.0024	CcSEcCtD
Lercanidipine—Stomatitis—Capecitabine—colon cancer	0.000662	0.00239	CcSEcCtD
Lercanidipine—Jaundice—Capecitabine—colon cancer	0.000662	0.00239	CcSEcCtD
Lercanidipine—Confusional state—Irinotecan—colon cancer	0.000652	0.00236	CcSEcCtD
Lercanidipine—Nervous system disorder—Vincristine—colon cancer	0.000651	0.00235	CcSEcCtD
Lercanidipine—Thrombocytopenia—Vincristine—colon cancer	0.00065	0.00235	CcSEcCtD
Lercanidipine—Chest pain—Fluorouracil—colon cancer	0.000646	0.00233	CcSEcCtD
Lercanidipine—Myalgia—Fluorouracil—colon cancer	0.000646	0.00233	CcSEcCtD
Lercanidipine—Hyperhidrosis—Vincristine—colon cancer	0.000642	0.00232	CcSEcCtD
Lercanidipine—Hepatobiliary disease—Capecitabine—colon cancer	0.000642	0.00232	CcSEcCtD
Lercanidipine—Discomfort—Fluorouracil—colon cancer	0.000639	0.00231	CcSEcCtD
Lercanidipine—Shock—Irinotecan—colon cancer	0.000636	0.0023	CcSEcCtD
Lercanidipine—Nervous system disorder—Irinotecan—colon cancer	0.000634	0.00229	CcSEcCtD
Lercanidipine—Agranulocytosis—Capecitabine—colon cancer	0.000633	0.00229	CcSEcCtD
Lercanidipine—Thrombocytopenia—Irinotecan—colon cancer	0.000633	0.00229	CcSEcCtD
Lercanidipine—Anorexia—Vincristine—colon cancer	0.000633	0.00229	CcSEcCtD
Lercanidipine—Hyperhidrosis—Irinotecan—colon cancer	0.000625	0.00226	CcSEcCtD
Lercanidipine—Confusional state—Fluorouracil—colon cancer	0.000625	0.00226	CcSEcCtD
Lercanidipine—Hypotension—Vincristine—colon cancer	0.000621	0.00224	CcSEcCtD
Lercanidipine—Anorexia—Irinotecan—colon cancer	0.000617	0.00223	CcSEcCtD
Lercanidipine—Rhinitis—Capecitabine—colon cancer	0.000611	0.00221	CcSEcCtD
Lercanidipine—Hepatitis—Capecitabine—colon cancer	0.000609	0.0022	CcSEcCtD
Lercanidipine—Nervous system disorder—Fluorouracil—colon cancer	0.000608	0.00219	CcSEcCtD
Lercanidipine—Thrombocytopenia—Fluorouracil—colon cancer	0.000607	0.00219	CcSEcCtD
Lercanidipine—Musculoskeletal discomfort—Vincristine—colon cancer	0.000605	0.00219	CcSEcCtD
Lercanidipine—Tachycardia—Fluorouracil—colon cancer	0.000605	0.00218	CcSEcCtD
Lercanidipine—Hypotension—Irinotecan—colon cancer	0.000604	0.00218	CcSEcCtD
Lercanidipine—Urinary tract disorder—Capecitabine—colon cancer	0.000602	0.00217	CcSEcCtD
Lercanidipine—Insomnia—Vincristine—colon cancer	0.000601	0.00217	CcSEcCtD
Lercanidipine—Oedema peripheral—Capecitabine—colon cancer	0.0006	0.00217	CcSEcCtD
Lercanidipine—Connective tissue disorder—Capecitabine—colon cancer	0.000599	0.00216	CcSEcCtD
Lercanidipine—Urethral disorder—Capecitabine—colon cancer	0.000597	0.00216	CcSEcCtD
Lercanidipine—Paraesthesia—Vincristine—colon cancer	0.000596	0.00215	CcSEcCtD
Lercanidipine—Breast disorder—Methotrexate—colon cancer	0.000593	0.00214	CcSEcCtD
Lercanidipine—Anorexia—Fluorouracil—colon cancer	0.000591	0.00213	CcSEcCtD
Lercanidipine—Toxic epidermal necrolysis—Methotrexate—colon cancer	0.00059	0.00213	CcSEcCtD
Lercanidipine—Insomnia—Irinotecan—colon cancer	0.000585	0.00211	CcSEcCtD
Lercanidipine—Paraesthesia—Irinotecan—colon cancer	0.000581	0.0021	CcSEcCtD
Lercanidipine—Hypotension—Fluorouracil—colon cancer	0.000579	0.00209	CcSEcCtD
Lercanidipine—Decreased appetite—Vincristine—colon cancer	0.000577	0.00209	CcSEcCtD
Lercanidipine—Dyspnoea—Irinotecan—colon cancer	0.000577	0.00208	CcSEcCtD
Lercanidipine—Erythema multiforme—Capecitabine—colon cancer	0.000576	0.00208	CcSEcCtD
Lercanidipine—Somnolence—Irinotecan—colon cancer	0.000575	0.00208	CcSEcCtD
Lercanidipine—Gastrointestinal disorder—Vincristine—colon cancer	0.000573	0.00207	CcSEcCtD
Lercanidipine—Fatigue—Vincristine—colon cancer	0.000573	0.00207	CcSEcCtD
Lercanidipine—Eye disorder—Capecitabine—colon cancer	0.000569	0.00206	CcSEcCtD
Lercanidipine—Dyspepsia—Irinotecan—colon cancer	0.000569	0.00206	CcSEcCtD
Lercanidipine—Tinnitus—Capecitabine—colon cancer	0.000568	0.00205	CcSEcCtD
Lercanidipine—Constipation—Vincristine—colon cancer	0.000568	0.00205	CcSEcCtD
Lercanidipine—Asthma—Methotrexate—colon cancer	0.000567	0.00205	CcSEcCtD
Lercanidipine—Flushing—Capecitabine—colon cancer	0.000566	0.00204	CcSEcCtD
Lercanidipine—Cardiac disorder—Capecitabine—colon cancer	0.000566	0.00204	CcSEcCtD
Lercanidipine—Musculoskeletal discomfort—Fluorouracil—colon cancer	0.000564	0.00204	CcSEcCtD
Lercanidipine—Decreased appetite—Irinotecan—colon cancer	0.000562	0.00203	CcSEcCtD
Lercanidipine—Insomnia—Fluorouracil—colon cancer	0.00056	0.00202	CcSEcCtD
Lercanidipine—Gastrointestinal disorder—Irinotecan—colon cancer	0.000558	0.00202	CcSEcCtD
Lercanidipine—Fatigue—Irinotecan—colon cancer	0.000558	0.00201	CcSEcCtD
Lercanidipine—Paraesthesia—Fluorouracil—colon cancer	0.000556	0.00201	CcSEcCtD
Lercanidipine—Pancreatitis—Methotrexate—colon cancer	0.000556	0.00201	CcSEcCtD
Lercanidipine—Constipation—Irinotecan—colon cancer	0.000553	0.002	CcSEcCtD
Lercanidipine—Angiopathy—Capecitabine—colon cancer	0.000553	0.002	CcSEcCtD
Lercanidipine—Dyspnoea—Fluorouracil—colon cancer	0.000552	0.00199	CcSEcCtD
Lercanidipine—Somnolence—Fluorouracil—colon cancer	0.000551	0.00199	CcSEcCtD
Lercanidipine—Immune system disorder—Capecitabine—colon cancer	0.00055	0.00199	CcSEcCtD
Lercanidipine—Mediastinal disorder—Capecitabine—colon cancer	0.000549	0.00198	CcSEcCtD
Lercanidipine—Dyspepsia—Fluorouracil—colon cancer	0.000545	0.00197	CcSEcCtD
Lercanidipine—Gastrointestinal pain—Vincristine—colon cancer	0.000543	0.00196	CcSEcCtD
Lercanidipine—Decreased appetite—Fluorouracil—colon cancer	0.000539	0.00194	CcSEcCtD
Lercanidipine—Alopecia—Capecitabine—colon cancer	0.000538	0.00194	CcSEcCtD
Lercanidipine—Pancytopenia—Methotrexate—colon cancer	0.000538	0.00194	CcSEcCtD
Lercanidipine—Gastrointestinal disorder—Fluorouracil—colon cancer	0.000535	0.00193	CcSEcCtD
Lercanidipine—Mental disorder—Capecitabine—colon cancer	0.000534	0.00193	CcSEcCtD
Lercanidipine—Feeling abnormal—Irinotecan—colon cancer	0.000533	0.00192	CcSEcCtD
Lercanidipine—Erythema—Capecitabine—colon cancer	0.00053	0.00192	CcSEcCtD
Lercanidipine—Malnutrition—Capecitabine—colon cancer	0.00053	0.00192	CcSEcCtD
Lercanidipine—Neutropenia—Methotrexate—colon cancer	0.00053	0.00191	CcSEcCtD
Lercanidipine—Gastrointestinal pain—Irinotecan—colon cancer	0.000529	0.00191	CcSEcCtD
Lercanidipine—Body temperature increased—Vincristine—colon cancer	0.000525	0.0019	CcSEcCtD
Lercanidipine—Abdominal pain—Vincristine—colon cancer	0.000525	0.0019	CcSEcCtD
Lercanidipine—Erectile dysfunction—Methotrexate—colon cancer	0.000522	0.00188	CcSEcCtD
Lercanidipine—Dysgeusia—Capecitabine—colon cancer	0.000519	0.00188	CcSEcCtD
Lercanidipine—Photosensitivity reaction—Methotrexate—colon cancer	0.000517	0.00187	CcSEcCtD
Lercanidipine—Abdominal pain—Irinotecan—colon cancer	0.000511	0.00185	CcSEcCtD
Lercanidipine—Body temperature increased—Irinotecan—colon cancer	0.000511	0.00185	CcSEcCtD
Lercanidipine—Feeling abnormal—Fluorouracil—colon cancer	0.000511	0.00184	CcSEcCtD
Lercanidipine—Muscle spasms—Capecitabine—colon cancer	0.00051	0.00184	CcSEcCtD
Lercanidipine—Stevens-Johnson syndrome—Methotrexate—colon cancer	0.000501	0.00181	CcSEcCtD
Lercanidipine—Vision blurred—Capecitabine—colon cancer	0.0005	0.00181	CcSEcCtD
Lercanidipine—Renal failure—Methotrexate—colon cancer	0.000497	0.00179	CcSEcCtD
Lercanidipine—Stomatitis—Methotrexate—colon cancer	0.000493	0.00178	CcSEcCtD
Lercanidipine—Ill-defined disorder—Capecitabine—colon cancer	0.000492	0.00178	CcSEcCtD
Lercanidipine—Urticaria—Fluorouracil—colon cancer	0.000492	0.00178	CcSEcCtD
Lercanidipine—Anaemia—Capecitabine—colon cancer	0.00049	0.00177	CcSEcCtD
Lercanidipine—Body temperature increased—Fluorouracil—colon cancer	0.00049	0.00177	CcSEcCtD
Lercanidipine—Hypersensitivity—Vincristine—colon cancer	0.000489	0.00177	CcSEcCtD
Lercanidipine—Malaise—Capecitabine—colon cancer	0.000478	0.00173	CcSEcCtD
Lercanidipine—Hepatobiliary disease—Methotrexate—colon cancer	0.000478	0.00173	CcSEcCtD
Lercanidipine—Vertigo—Capecitabine—colon cancer	0.000477	0.00172	CcSEcCtD
Lercanidipine—Hypersensitivity—Irinotecan—colon cancer	0.000477	0.00172	CcSEcCtD
Lercanidipine—Asthenia—Vincristine—colon cancer	0.000477	0.00172	CcSEcCtD
Lercanidipine—Syncope—Capecitabine—colon cancer	0.000476	0.00172	CcSEcCtD
Lercanidipine—Agranulocytosis—Methotrexate—colon cancer	0.000472	0.0017	CcSEcCtD
Lercanidipine—Palpitations—Capecitabine—colon cancer	0.000469	0.00169	CcSEcCtD
Lercanidipine—Loss of consciousness—Capecitabine—colon cancer	0.000466	0.00168	CcSEcCtD
Lercanidipine—Asthenia—Irinotecan—colon cancer	0.000464	0.00168	CcSEcCtD
Lercanidipine—Cough—Capecitabine—colon cancer	0.000463	0.00167	CcSEcCtD
Lercanidipine—Hypersensitivity—Fluorouracil—colon cancer	0.000456	0.00165	CcSEcCtD
Lercanidipine—Diarrhoea—Vincristine—colon cancer	0.000454	0.00164	CcSEcCtD
Lercanidipine—Hepatitis—Methotrexate—colon cancer	0.000454	0.00164	CcSEcCtD
Lercanidipine—Chest pain—Capecitabine—colon cancer	0.000452	0.00163	CcSEcCtD
Lercanidipine—Arthralgia—Capecitabine—colon cancer	0.000452	0.00163	CcSEcCtD
Lercanidipine—Myalgia—Capecitabine—colon cancer	0.000452	0.00163	CcSEcCtD
Lercanidipine—Anxiety—Capecitabine—colon cancer	0.00045	0.00163	CcSEcCtD
Lercanidipine—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—colon cancer	0.000448	0.00162	CcSEcCtD
Lercanidipine—Urinary tract disorder—Methotrexate—colon cancer	0.000448	0.00162	CcSEcCtD
Lercanidipine—Discomfort—Capecitabine—colon cancer	0.000446	0.00161	CcSEcCtD
Lercanidipine—Urethral disorder—Methotrexate—colon cancer	0.000445	0.00161	CcSEcCtD
Lercanidipine—Diarrhoea—Irinotecan—colon cancer	0.000443	0.0016	CcSEcCtD
Lercanidipine—Dry mouth—Capecitabine—colon cancer	0.000442	0.00159	CcSEcCtD
Lercanidipine—Dizziness—Vincristine—colon cancer	0.000439	0.00159	CcSEcCtD
Lercanidipine—Pruritus—Fluorouracil—colon cancer	0.000438	0.00158	CcSEcCtD
Lercanidipine—Confusional state—Capecitabine—colon cancer	0.000437	0.00158	CcSEcCtD
Lercanidipine—Erythema multiforme—Methotrexate—colon cancer	0.000429	0.00155	CcSEcCtD
Lercanidipine—Dizziness—Irinotecan—colon cancer	0.000428	0.00154	CcSEcCtD
Lercanidipine—Shock—Capecitabine—colon cancer	0.000426	0.00154	CcSEcCtD
Lercanidipine—Nervous system disorder—Capecitabine—colon cancer	0.000425	0.00153	CcSEcCtD
Lercanidipine—Eye disorder—Methotrexate—colon cancer	0.000424	0.00153	CcSEcCtD
Lercanidipine—Diarrhoea—Fluorouracil—colon cancer	0.000424	0.00153	CcSEcCtD
Lercanidipine—Thrombocytopenia—Capecitabine—colon cancer	0.000424	0.00153	CcSEcCtD
Lercanidipine—Tinnitus—Methotrexate—colon cancer	0.000423	0.00153	CcSEcCtD
Lercanidipine—Tachycardia—Capecitabine—colon cancer	0.000423	0.00153	CcSEcCtD
Lercanidipine—Vomiting—Vincristine—colon cancer	0.000422	0.00153	CcSEcCtD
Lercanidipine—Cardiac disorder—Methotrexate—colon cancer	0.000421	0.00152	CcSEcCtD
Lercanidipine—Skin disorder—Capecitabine—colon cancer	0.000421	0.00152	CcSEcCtD
Lercanidipine—Rash—Vincristine—colon cancer	0.000419	0.00151	CcSEcCtD
Lercanidipine—Hyperhidrosis—Capecitabine—colon cancer	0.000419	0.00151	CcSEcCtD
Lercanidipine—Dermatitis—Vincristine—colon cancer	0.000418	0.00151	CcSEcCtD
Lercanidipine—Headache—Vincristine—colon cancer	0.000416	0.0015	CcSEcCtD
Lercanidipine—Anorexia—Capecitabine—colon cancer	0.000413	0.00149	CcSEcCtD
Lercanidipine—Angiopathy—Methotrexate—colon cancer	0.000412	0.00149	CcSEcCtD
Lercanidipine—Vomiting—Irinotecan—colon cancer	0.000411	0.00149	CcSEcCtD
Lercanidipine—Immune system disorder—Methotrexate—colon cancer	0.00041	0.00148	CcSEcCtD
Lercanidipine—Dizziness—Fluorouracil—colon cancer	0.00041	0.00148	CcSEcCtD
Lercanidipine—Mediastinal disorder—Methotrexate—colon cancer	0.000409	0.00148	CcSEcCtD
Lercanidipine—Rash—Irinotecan—colon cancer	0.000408	0.00147	CcSEcCtD
Lercanidipine—Dermatitis—Irinotecan—colon cancer	0.000407	0.00147	CcSEcCtD
Lercanidipine—Headache—Irinotecan—colon cancer	0.000405	0.00146	CcSEcCtD
Lercanidipine—Hypotension—Capecitabine—colon cancer	0.000405	0.00146	CcSEcCtD
Lercanidipine—Alopecia—Methotrexate—colon cancer	0.000401	0.00145	CcSEcCtD
Lercanidipine—Mental disorder—Methotrexate—colon cancer	0.000397	0.00144	CcSEcCtD
Lercanidipine—Erythema—Methotrexate—colon cancer	0.000395	0.00143	CcSEcCtD
Lercanidipine—Malnutrition—Methotrexate—colon cancer	0.000395	0.00143	CcSEcCtD
Lercanidipine—Nausea—Vincristine—colon cancer	0.000395	0.00142	CcSEcCtD
Lercanidipine—Musculoskeletal discomfort—Capecitabine—colon cancer	0.000394	0.00142	CcSEcCtD
Lercanidipine—Vomiting—Fluorouracil—colon cancer	0.000394	0.00142	CcSEcCtD
Lercanidipine—Insomnia—Capecitabine—colon cancer	0.000392	0.00141	CcSEcCtD
Lercanidipine—Rash—Fluorouracil—colon cancer	0.000391	0.00141	CcSEcCtD
Lercanidipine—Dermatitis—Fluorouracil—colon cancer	0.00039	0.00141	CcSEcCtD
Lercanidipine—Paraesthesia—Capecitabine—colon cancer	0.000389	0.0014	CcSEcCtD
Lercanidipine—Headache—Fluorouracil—colon cancer	0.000388	0.0014	CcSEcCtD
Lercanidipine—Dysgeusia—Methotrexate—colon cancer	0.000387	0.0014	CcSEcCtD
Lercanidipine—Dyspnoea—Capecitabine—colon cancer	0.000386	0.00139	CcSEcCtD
Lercanidipine—Nausea—Irinotecan—colon cancer	0.000384	0.00139	CcSEcCtD
Lercanidipine—Dyspepsia—Capecitabine—colon cancer	0.000381	0.00138	CcSEcCtD
Lercanidipine—Decreased appetite—Capecitabine—colon cancer	0.000376	0.00136	CcSEcCtD
Lercanidipine—Gastrointestinal disorder—Capecitabine—colon cancer	0.000374	0.00135	CcSEcCtD
Lercanidipine—Fatigue—Capecitabine—colon cancer	0.000373	0.00135	CcSEcCtD
Lercanidipine—Vision blurred—Methotrexate—colon cancer	0.000372	0.00134	CcSEcCtD
Lercanidipine—Constipation—Capecitabine—colon cancer	0.00037	0.00134	CcSEcCtD
Lercanidipine—Nausea—Fluorouracil—colon cancer	0.000368	0.00133	CcSEcCtD
Lercanidipine—Ill-defined disorder—Methotrexate—colon cancer	0.000366	0.00132	CcSEcCtD
Lercanidipine—Anaemia—Methotrexate—colon cancer	0.000365	0.00132	CcSEcCtD
Lercanidipine—Feeling abnormal—Capecitabine—colon cancer	0.000357	0.00129	CcSEcCtD
Lercanidipine—Malaise—Methotrexate—colon cancer	0.000356	0.00129	CcSEcCtD
Lercanidipine—Vertigo—Methotrexate—colon cancer	0.000355	0.00128	CcSEcCtD
Lercanidipine—Gastrointestinal pain—Capecitabine—colon cancer	0.000354	0.00128	CcSEcCtD
Lercanidipine—Cough—Methotrexate—colon cancer	0.000345	0.00124	CcSEcCtD
Lercanidipine—Urticaria—Capecitabine—colon cancer	0.000344	0.00124	CcSEcCtD
Lercanidipine—Body temperature increased—Capecitabine—colon cancer	0.000342	0.00124	CcSEcCtD
Lercanidipine—Abdominal pain—Capecitabine—colon cancer	0.000342	0.00124	CcSEcCtD
Lercanidipine—Arthralgia—Methotrexate—colon cancer	0.000336	0.00121	CcSEcCtD
Lercanidipine—Chest pain—Methotrexate—colon cancer	0.000336	0.00121	CcSEcCtD
Lercanidipine—Myalgia—Methotrexate—colon cancer	0.000336	0.00121	CcSEcCtD
Lercanidipine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—colon cancer	0.000334	0.00121	CcSEcCtD
Lercanidipine—Discomfort—Methotrexate—colon cancer	0.000332	0.0012	CcSEcCtD
Lercanidipine—Confusional state—Methotrexate—colon cancer	0.000325	0.00117	CcSEcCtD
Lercanidipine—Hypersensitivity—Capecitabine—colon cancer	0.000319	0.00115	CcSEcCtD
Lercanidipine—Nervous system disorder—Methotrexate—colon cancer	0.000316	0.00114	CcSEcCtD
Lercanidipine—Thrombocytopenia—Methotrexate—colon cancer	0.000316	0.00114	CcSEcCtD
Lercanidipine—Skin disorder—Methotrexate—colon cancer	0.000313	0.00113	CcSEcCtD
Lercanidipine—Hyperhidrosis—Methotrexate—colon cancer	0.000312	0.00113	CcSEcCtD
Lercanidipine—Asthenia—Capecitabine—colon cancer	0.000311	0.00112	CcSEcCtD
Lercanidipine—Anorexia—Methotrexate—colon cancer	0.000307	0.00111	CcSEcCtD
Lercanidipine—Pruritus—Capecitabine—colon cancer	0.000306	0.00111	CcSEcCtD
Lercanidipine—Hypotension—Methotrexate—colon cancer	0.000301	0.00109	CcSEcCtD
Lercanidipine—Diarrhoea—Capecitabine—colon cancer	0.000296	0.00107	CcSEcCtD
Lercanidipine—Musculoskeletal discomfort—Methotrexate—colon cancer	0.000294	0.00106	CcSEcCtD
Lercanidipine—Insomnia—Methotrexate—colon cancer	0.000291	0.00105	CcSEcCtD
Lercanidipine—Paraesthesia—Methotrexate—colon cancer	0.000289	0.00105	CcSEcCtD
Lercanidipine—Dyspnoea—Methotrexate—colon cancer	0.000287	0.00104	CcSEcCtD
Lercanidipine—Somnolence—Methotrexate—colon cancer	0.000287	0.00103	CcSEcCtD
Lercanidipine—Dizziness—Capecitabine—colon cancer	0.000286	0.00103	CcSEcCtD
Lercanidipine—Dyspepsia—Methotrexate—colon cancer	0.000284	0.00102	CcSEcCtD
Lercanidipine—Decreased appetite—Methotrexate—colon cancer	0.00028	0.00101	CcSEcCtD
Lercanidipine—Gastrointestinal disorder—Methotrexate—colon cancer	0.000278	0.001	CcSEcCtD
Lercanidipine—Fatigue—Methotrexate—colon cancer	0.000278	0.001	CcSEcCtD
Lercanidipine—Vomiting—Capecitabine—colon cancer	0.000275	0.000994	CcSEcCtD
Lercanidipine—Rash—Capecitabine—colon cancer	0.000273	0.000986	CcSEcCtD
Lercanidipine—Dermatitis—Capecitabine—colon cancer	0.000273	0.000985	CcSEcCtD
Lercanidipine—Headache—Capecitabine—colon cancer	0.000271	0.000979	CcSEcCtD
Lercanidipine—Feeling abnormal—Methotrexate—colon cancer	0.000266	0.000959	CcSEcCtD
Lercanidipine—Gastrointestinal pain—Methotrexate—colon cancer	0.000264	0.000952	CcSEcCtD
Lercanidipine—Nausea—Capecitabine—colon cancer	0.000257	0.000929	CcSEcCtD
Lercanidipine—Urticaria—Methotrexate—colon cancer	0.000256	0.000925	CcSEcCtD
Lercanidipine—Body temperature increased—Methotrexate—colon cancer	0.000255	0.00092	CcSEcCtD
Lercanidipine—Abdominal pain—Methotrexate—colon cancer	0.000255	0.00092	CcSEcCtD
Lercanidipine—Hypersensitivity—Methotrexate—colon cancer	0.000237	0.000857	CcSEcCtD
Lercanidipine—Asthenia—Methotrexate—colon cancer	0.000231	0.000835	CcSEcCtD
Lercanidipine—Pruritus—Methotrexate—colon cancer	0.000228	0.000823	CcSEcCtD
Lercanidipine—Diarrhoea—Methotrexate—colon cancer	0.000221	0.000796	CcSEcCtD
Lercanidipine—Dizziness—Methotrexate—colon cancer	0.000213	0.00077	CcSEcCtD
Lercanidipine—Vomiting—Methotrexate—colon cancer	0.000205	0.00074	CcSEcCtD
Lercanidipine—Rash—Methotrexate—colon cancer	0.000203	0.000734	CcSEcCtD
Lercanidipine—Dermatitis—Methotrexate—colon cancer	0.000203	0.000733	CcSEcCtD
Lercanidipine—Headache—Methotrexate—colon cancer	0.000202	0.000729	CcSEcCtD
Lercanidipine—Nausea—Methotrexate—colon cancer	0.000191	0.000691	CcSEcCtD
